The Vanguard Group 13D and 13G filings for DexCom, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | DexCom, Inc. DXCM |
The Vanguard Group | 44,467,151 11.510% |
647,315 (+1.48%) |
Filing |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | DexCom, Inc. DXCM |
The Vanguard Group | 43,819,836 11.340% |
2,178,560 (+5.23%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | DexCom, Inc. DXCM |
The Vanguard Group | 41,641,276 10.740% |
712,296 (+1.74%) |
Filing |
| 2021-02-10 10:46 am Sale |
2020-12-31 | 13G | DexCom, Inc. DXCM |
The Vanguard Group | 40,928,980 10.660% |
-690,716 (-1.66%) |
Filing |
| 2020-06-10 10:24 am Purchase |
2020-05-29 | 13G | DexCom, Inc. DXCM |
The Vanguard Group | 41,619,696 11.270% |
7,750,756 (+22.88%) |
Filing |